Sinopharm, China’s giant state-owned pharmaceutical company, has closed the purchase of a 57% stake in Winteam Pharmaceutical Group Ltd.  Sinopharm paid about $252 million to make the acquisition. Winteam, whose headquarters are in Hong Kong, operates in mainland China. The company makes TCM preparations, western-style chemical drugs and biologics. The acquisition builds Sinopharm’s portfolio, especially in the area of TCM drugs. More details..... Stock Symbol: (HK: 0570) Share this with colleagues: // //